Total Payments
$892.93
2024 Payments
$74.20
Companies
12
Transactions
26
Medicare Patients
5,033
Medicare Billing
$397,679
Payment Breakdown by Category
Food & Beverage$420.51 (47.1%)
Research$417.00 (46.7%)
Education$55.42 (6.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $420.51 | 20 | 47.1% |
| Unspecified | $417.00 | 1 | 46.7% |
| Education | $55.42 | 5 | 6.2% |
Payments by Type
General
$475.93
25 transactions
Research
$417.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $448.53 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $137.80 | 7 | $0 (2023) |
| Daiichi Sankyo Inc. | $88.82 | 4 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $59.20 | 1 | $0 (2024) |
| PFIZER INC. | $54.78 | 3 | $0 (2023) |
| Seagen Inc. | $17.84 | 1 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.35 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $16.11 | 1 | $0 (2023) |
| Cumberland Pharmaceuticals, Inc. | $15.00 | 1 | $0 (2024) |
| MorphoSys, US Inc. | $14.61 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74.20 | 2 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($59.20) |
| 2023 | $178.58 | 9 | Daiichi Sankyo Inc. ($68.54) |
| 2022 | $128.53 | 7 | Novartis Pharmaceuticals Corporation ($75.33) |
| 2020 | $11.60 | 1 | Exelixis Inc. ($11.60) |
| 2019 | $39.20 | 2 | Novartis Pharmaceuticals Corporation ($39.20) |
| 2018 | $43.82 | 4 | Celgene Corporation ($31.53) |
| 2017 | $417.00 | 1 | Celgene Corporation ($417.00) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Cumberland Pharmaceuticals, Inc. | SANCUSO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $59.20 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/10/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2023 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Oncology | ||||||
| 04/24/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.27 | General |
| 04/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/08/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/02/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/25/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Oncology | ||||||
| 01/05/2023 | PFIZER INC. | ELIQUIS (Drug), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/14/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2022 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/01/2022 | PFIZER INC. | XYNTHA (Biological), BENEFIX, COMIRNATY | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: HEMATOLOGY | ||||||
| 11/15/2022 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Oncology | ||||||
| 11/10/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: ONCOLOGY | ||||||
| 04/01/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2020 | Exelixis Inc. | Cabometyx (Drug) | Education | In-kind items and services | $11.60 | General |
| Category: Oncology | ||||||
| 06/25/2019 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2019 | Novartis Pharmaceuticals Corporation | TASIGNA (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: HEMATOLOGY | ||||||
| 08/10/2018 | Celgene Corporation | Pomalyst (Drug) | Education | In-kind items and services | $10.51 | General |
| Category: Hematology / Oncology | ||||||
| 07/27/2018 | Celgene Corporation | — | Education | In-kind items and services | $10.51 | General |
| 07/27/2018 | Celgene Corporation | Pomalyst (Drug) | Education | In-kind items and services | $10.51 | General |
| Category: Hematology / Oncology | ||||||
| 03/29/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| AZA-MDS-006 | Celgene Corporation | $417.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 962 | 2,127 | $356,712 | $74,846 |
| 2022 | 11 | 989 | 2,138 | $373,690 | $84,362 |
| 2021 | 13 | 1,415 | 3,126 | $441,747 | $119,565 |
| 2020 | 13 | 1,667 | 3,772 | $506,265 | $118,906 |
Total Patients
5,033
Total Services
11,163
Medicare Billing
$397,679
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 347 | $147,475 | $28,518 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 220 | $66,000 | $12,394 | 18.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 59 | $20,060 | $5,226 | 26.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 219 | 590 | $7,080 | $4,956 | 70.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 221 | 612 | $24,480 | $4,645 | 19.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 36 | $21,528 | $4,620 | 21.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 29 | $19,024 | $3,744 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $18,216 | $3,618 | 19.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 61 | $14,396 | $3,590 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $11,696 | $2,263 | 19.3% |
| 36591 | Collection of blood sample from implanted device | Office | 2023 | 19 | 46 | $3,910 | $831.60 | 21.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 39 | $2,769 | $393.68 | 14.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 39 | $78.00 | $47.09 | 60.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 430 | $160,985 | $36,071 | 22.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 173 | 279 | $71,041 | $16,207 | 22.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 47 | 49 | $30,981 | $7,074 | 22.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 215 | 584 | $23,291 | $4,482 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 33 | $16,966 | $4,231 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $18,158 | $4,089 | 22.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 21 | 21 | $14,832 | $3,413 | 23.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 42 | $13,996 | $3,216 | 23.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 52 | $11,962 | $2,778 | 23.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 217 | 551 | $6,453 | $1,633 | 25.3% |
| 36591 | Collection of blood sample from implanted device | Office | 2022 | 21 | 62 | $5,025 | $1,167 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 259 | 597 | $182,330 | $53,109 | 29.1% |
About Dr. Michael Thompson, MD
Dr. Michael Thompson, MD is a Hematology & Oncology healthcare provider based in Oak Ridge, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023016631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Thompson, MD has received a total of $892.93 in payments from pharmaceutical and medical device companies, with $74.20 received in 2024. These payments were reported across 26 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($420.51).
As a Medicare-enrolled provider, Thompson has provided services to 5,033 Medicare beneficiaries, totaling 11,163 services with total Medicare billing of $397,679. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Oak Ridge, TN
- Active Since 07/08/2005
- Last Updated 08/24/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1023016631
Products in Payments
- CC-486 (Drug) $417.00
- MEKINIST (Drug) $96.42
- INJECTAFER (Drug) $59.38
- LifeVest (Device) $59.20
- ELIQUIS (Drug) $39.70
- Enhertu (Drug) $29.44
- Pomalyst (Drug) $21.02
- TASIGNA (Drug) $18.11
- TUKYSA (Drug) $17.84
- NINLARO (Drug) $16.35
- OPDIVO (Biological) $16.11
- XYNTHA (Biological) $15.08
- SANCUSO (Drug) $15.00
- MONJUVI (Drug) $14.61
- ADCETRIS (Biological) $12.29
- Cabometyx (Drug) $11.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oak Ridge
Dr. John Foust, Md, MD
Hematology & Oncology — Payments: $16,229
Hematology & Oncology $16,229
Namratha Vontela, M.d, M.D
Hematology & Oncology — Payments: $1,180
Hematology & Oncology $1,180
Dr. Catherine Murphree, Md, MD
Hematology & Oncology — Payments: $1,014
Hematology & Oncology $1,014
Dr. Thomas Repine, Md, MD
Hematology & Oncology — Payments: $459.87
Hematology & Oncology $459.87